These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 39008455)

  • 1. The peer effects of corporate poverty alleviation behavior: Empirical evidence from China.
    Fang K; Zheng L; Zhai N
    PLoS One; 2024; 19(7):e0304252. PubMed ID: 39008455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does CSR affect the cost of equity capital: Empirical evidence from the targeted poverty alleviation of listed companies in China.
    Yi Y; Xie B; Zhou L; Wei Y
    PLoS One; 2020; 15(2):e0227952. PubMed ID: 32032381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted poverty alleviation initiatives and corporate sustainable value creation: Determining the role of corporate internal governance control in China.
    Bin-Feng C; Zhe L; Mirza SS; Safdar R
    Heliyon; 2023 Jul; 9(7):e17686. PubMed ID: 37449183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do industry and province attributes impact corporate contribution to poverty alleviation: A multilevel analysis.
    Chen S; Yang G
    PLoS One; 2023; 18(10):e0293505. PubMed ID: 37883369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Government Official Assessment on Ecological Poverty Alleviation: Evidence from Chinese Listed Companies.
    Huang Y
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Environmental Tax on Corporate Sustainable Performance: Insights from High-Tech Firms in China.
    Zhao X; Li J; Li Y
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tax incentives and environmental, social, and governance performance: empirical evidence from China.
    Zhu N; Zhou Y; Zhang S; Yan J
    Environ Sci Pollut Res Int; 2023 Apr; 30(19):54899-54913. PubMed ID: 36881223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corporate social responsibility, political connections, and barrier industry diversification: Evidence from China.
    Zhang Z; Wang W; Wen S
    Heliyon; 2024 Apr; 10(8):e29953. PubMed ID: 38699717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driving force of value reversal in Chinese overleveraged firms: The mechanism and path of private placement.
    Song X; Liu X; Chen H
    PLoS One; 2024; 19(5):e0303544. PubMed ID: 38739674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smog, media attention, and corporate social responsibility-empirical evidence from Chinese polluting listed companies.
    Xiong G; Luo Y
    Environ Sci Pollut Res Int; 2021 Sep; 28(34):46116-46129. PubMed ID: 33410010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Officials' promotion expectation, corporate strategic deviance and corporate growth in China: The moderating effect of corporate ownership.
    Li Y; Fang X
    PLoS One; 2023; 18(8):e0284872. PubMed ID: 37624770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for poverty alleviation supply chain with government subsidies and misreporting behavior in China.
    Ye F; Deng Q
    PLoS One; 2021; 16(7):e0253761. PubMed ID: 34264982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of R&D innovation and political background on corporate growth: A study based on private listed companies in China.
    Kong X; Chen H; Wu P; Ma R; Pan F
    PLoS One; 2024; 19(5):e0297329. PubMed ID: 38723045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Official Turnover and Corporate ESG Practices: Evidence from China.
    Yang Y; Xu G; Li R
    Environ Sci Pollut Res Int; 2023 Apr; 30(18):51422-51439. PubMed ID: 36809631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of financial poverty alleviation efficiency: Evidence from Henan, China.
    Liu Q
    PLoS One; 2022; 17(11):e0277354. PubMed ID: 36355711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health poverty alleviation in China from the perspective of historical institutionalism: policy changes and driving factors.
    Xu L; You X; Cui Y; You J
    Front Public Health; 2023; 11():1265588. PubMed ID: 38298260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sincerity or hypocrisy: can green M&A achieve corporate environmental governance?
    Zhao X; Jia M
    Environ Sci Pollut Res Int; 2022 Apr; 29(18):27339-27351. PubMed ID: 34978031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piercing the corporate veil system and creditors protection: Based on the investigation of debt paying ability--Empirical evidence from the 2005 Company Law amendment.
    Tian J; Chen Z; Zhu Y
    PLoS One; 2024; 19(5):e0302561. PubMed ID: 38718054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does digital transformation affect the ESG performance of Chinese manufacturing state-owned enterprises?-Based on the mediating mechanism of dynamic capabilities and the moderating mechanism of the institutional environment.
    Jin X; Wu Y
    PLoS One; 2024; 19(5):e0301864. PubMed ID: 38743669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State-owned capital and quality of green innovation: Evidence from Chinese listed private firms.
    Yan H; Chen Z; Yang Y
    Heliyon; 2024 Apr; 10(7):e28179. PubMed ID: 38560115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.